Belimumab in Lupus Nephritis Belimumab is a BLyS-specific inhibitor that is FDA approved for the treatment of active lupus and lupus nephritis, based on a few pivotal trials; and now a metanalysis supports its use in active lupus nephritis. https://t.co/f2odJWlyR2 https://t.co/y5exJIFzht